Q1 EPS Estimates for Henry Schein Decreased by William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at William Blair dropped their Q1 2025 earnings estimates for Henry Schein in a note issued to investors on Tuesday, March 11th. William Blair analyst B. Vazquez now anticipates that the company will post earnings per share of $1.10 for the quarter, down from their prior estimate of $1.16. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q2 2025 earnings at $1.17 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.25 EPS, FY2025 earnings at $4.87 EPS, Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.35 EPS and FY2026 earnings at $5.17 EPS.

Other analysts also recently issued research reports about the stock. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Mizuho began coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Trading Up 1.1 %

HSIC opened at $70.58 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.49. The business’s 50 day moving average is $74.81 and its two-hundred day moving average is $72.60. The firm has a market cap of $8.76 billion, a price-to-earnings ratio of 29.05, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year.

Institutional Trading of Henry Schein

Several institutional investors and hedge funds have recently modified their holdings of HSIC. Versant Capital Management Inc grew its holdings in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the last quarter. Investment Management Corp VA ADV purchased a new stake in Henry Schein during the 4th quarter worth about $32,000. Venturi Wealth Management LLC raised its stake in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC lifted its holdings in Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its stake in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.